Skin Care News

As kids return to school, the CDC has reminded the public that children with lice do not need to cut their school day short and be sent home early.

A low dose of interleukin-2 therapy showed positive results in the treatment of bullous pemphigoid with an early onset of response, according to a study.

The FDA has not approved a new sunscreen ingredient since the 1990s, leaving consumers and clinicians wondering why.

A panel of experts shared consensus statements on how to best manage adult acne, according to a study.

The FDA has cleared an investigational new drug application for a first-in-human phase 1/2 study of ATR-04 for moderate to severe dermal toxicity from epidermal growth factor receptor inhibitors, Azitra Inc. announced in a press release.

Timber Pharmaceutical’s study investigating the use of a new topical ointment formulation of isotretinoin for moderate to severe congenital ichthyosis did not achieve its endpoints, LEO Pharma announced in a press release.

In this episode, host Hansa Bhargava, MD, talks with Julia Kerolus, MD, FACS, about the MedSpa industry, the dangers of social media and its effect on cosmetic procedures among young adults, skin care and more.

Topical microencapsulated benzoyl peroxide improved the skin microbiome and physical properties and clinical symptoms among patients with rosacea, according to results of a study published in Journal of Clinical and Aesthetic Dermatology.

The FDA approved Nemluvio in the form of a prefilled pen for subcutaneous injection for the treatment of prurigo nodularis in adults, Galderma announced in a press release.

Nemolizumab doses of 30 mg and 60 mg with topical corticosteroid treatment yielded positive results in adolescent patients with prurigo nodularis, according to a study.